Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I just spoke to Tau, Nortrust is a brand new investor.
Insane decision given the spread on this .... Patience draft...
Can't be bothered to wait
This guy picked up tji tejoori 40 bagger, he's taken some of this It is a tiny (£2.1m) investment trust. It has $1.4m (£1.1m) in cash (30/6/2016 HY report) – this doesnt screen well as it is held via a subsidiary…. The rest is a 24% stake in Stopharm and a 16.35% stake held via a convertible bridge loan. This is valued at $6m (£4.8m) in the books based on an indicative offer. In total this gives an upside of over 150%. IF we get to NAV. Stolfarm is a Khazakhstan pharmacy plausibly forecast to make $1.9m in 2016 – so the total valuation of Stopharm gives a PE of about 8. Kazakhstan’s economy and exchange rate has been erratic – going from 185 per USD to 335! Apparently the economy has stabilised. Costs are $500-600k per year. This gives probably about 3 years to sell Stopharm until the company is in trouble… The offer which hasn’t actually materialised is from an insider – Capital Gate holding – originally announced 29th Sep 2014 – subject to monopolies approval. On 30 June 2016 there was another expression of interest. They are continuing to try and sell the stake. The company also potentially has value as a cash shell / vehicle for something else. Upside case is there is an offer for Stolpharm and the company distributes the money to shareholders and winds itself up – ideally at a large profit. Downside is the asset is stolen in some way or the company delists and its a slow journey to getting the money back. Shareholders are reasonably dispersed – largest is Richard Horlick – former director / founder.
Nurgul Zhaukeyeva Nurgul is a graduate of Adilet Law School and holds a dergree in law. Since May 2003, she served as the Director of the legal department of JSC "Air Astana" . Since May 2005, she held senior positions in various law firms in Almaty. Since March 2007, she has founded her own company "Capital Gate LLP", a firm providing legal, consulting and financial services. Nurgul Zhaukeyeva is specializing in corporate law and has an extended experience in organizing and structuring legal activity of major national companies, organization and participation in the public procurement system . During her work she led deals on acquisition of shares by non-resident legal entities in Kazakhstan, initiation and maintenance procedures for rehabilitation and bankruptcy of legal entities.
Tau Capital plc PDMR Shareholding The Company announces that it was informed yesterday that Capital Gate Holding LLP acquired 6,910,025 shares in the Company on 3 April 2014 at a price of USD0.145 per share. Capital Gate Holding LLP is wholly owned by Nurgul Zhaukeyeva who also wholly owns Capital Gate Securities Limited, the Investment Adviser to the Company. Following this transaction, Capital Gate Holding LLP owns 6,910,025 shares in the Company. This represents 9.34% of the Ordinary Shares in issue.
Another trade will come . Thanks Tau you
Nice work if you can afford it. gla @ Tau
Of the total share bought up today . gla @ The Tau
Looks like we could be onto a good thing . Well done all .
$0.27 on the near horizon . Good luck
Richard must be stocking up for the dividend ahead . Rude not to join him . gla @ Tau
30% + is getting large . I blame Richard for keep buying . gla @ The Tau
Hi folks, Just finished a two part review of all the Russia focused/related closed-end funds out there, including TAU - hope you'll take a look & comment: http://wexboy.wordpress.com/2012/03/11/from-russia-with-love/ Cheers, Wexboy
Tau announces that further to the announcement on 20 February 2012 that it intended to exercise its authority to buy back up to 10 per cent of the shares in issue with immediate effect, it has repurchased 11,491,538 shares at $0.4175. The repurchased shares will be cancelled as soon as possible. After such cancellation, Tau will have 226,958,464 shares in issue. As a result of the buy-back, Tau will have remaining authority to buy back a further 12,353,462 of the shares in issue, which it intends to continue to exercise in a way that addresses the discount and enhances NAV per share. In addition as previously announced the Board intends to seek approval at the next annual general meeting to renew the share buy back authority and proposes to implement an ongoing buy back of at least 8 per cent of the issued capital on an annual basis subject to the discount to NAV being 10 per cent or greater.
RNS Number : 9688S Tau Capital PLC 29 November 2011 TAU CAPITAL PLC ("Tau" or "the Company") APPROVAL FOR CONVERSION OF EQUITY Tau announces today that it has been granted approval by the Anti-Monopoly Commission of the Republic of Kazakhstan for conversion into equity of the remaining 16.35% interest in Stopharm LLP, the largest pharmaceutical distributor in Kazakhstan by volume. Post-conversion, which Tau anticipates will take place over the next two weeks, Tau will directly hold a 40.35% equity interest in Stopharm LLP. Further information, please contact: IOMA Fund & Investment Management Tel: +44 (0) 1624 Ltd 681250 Cynthia Edwards Numis Securities Limited Tel: +44 (0) 20 Nominated Adviser: Nick Westlake/Hugh 7260 1000 Jonathan Corporate Broking: Alex Ham This information is provided by RNS The company news service from the London Stock Exchange END MSCPGGBWGUPGGGB
Could see a good rise today) http://www.investegate.co.uk/Article.aspx?id=201003300700083787J